Upper Gastrointestinal Cancer: Delays in Diagnosis and Treatment Caused by Barriers to Healthcare in the Latino Community

We report a case of an 81-year-old male immigrant from a Latin American developing country with a high burden of upper gastrointestinal neoplasms, who presented with a small bowel gastrointestinal stromal tumor (GIST) after 2 years of delay in the diagnosis due to multiple barriers to healthcare. The patient presented with a partial intestinal obstruction in an abdominal computed tomography (CT) scan suggestive of a GIST. Surgical resection was performed, and adjuvant therapy was initiated with imatinib (a tyrosine kinase inhibitor) after the diagnosis was confirmed. The patient had a successful outcome. Due to his migratory status, the patient planned to follow up with different health providers in two different countries, which constitutes a common challenge in the immigrant population.

[1]  D. Morgan,et al.  Western Honduras Copán Population–Based Cancer Registry: Initial Estimates and a Model for Rural Central America , 2021, JCO global oncology.

[2]  S. Sleijfer,et al.  Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. Redden,et al.  HPV Vaccination Hesitancy Among Latina Immigrant Mothers Despite Physician Recommendation. , 2020, Ethnicity & disease.

[4]  D. Morgan,et al.  Novel academic center model for Spanish-speaking patients in the southeastern United States. , 2020, Preventive medicine and community health.

[5]  G. Calderillo,et al.  Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American Realities , 2020, JCO global oncology.

[6]  P. Fleming,et al.  U.S. Immigration Law Enforcement Practices and Health Inequities. , 2019, American journal of preventive medicine.

[7]  T. Hinojosa,et al.  Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database , 2019, Journal of Racial and Ethnic Health Disparities.

[8]  Prashanth Rawla,et al.  Epidemiology of gastric cancer: global trends, risk factors and prevention , 2018, Przeglad gastroenterologiczny.

[9]  D. Morgan,et al.  Health Barriers and Patterns of Gastric Cancer Care in Rural Central American Resource-Limited Settings , 2018, JAMA oncology.

[10]  P. Reichardt.  The Story of Imatinib in GIST - a Journey through the Development of a Targeted Therapy , 2018, Oncology Research and Treatment.

[11]  J. Søndergaard,et al.  Predictive values of upper gastrointestinal cancer alarm symptoms in the general population: a nationwide cohort study , 2018, BMC cancer.

[12]  J. Huo,et al.  Endoscopic resection of gastric gastrointestinal stromal tumors. , 2017, Translational gastroenterology and hepatology.

[13]  P. Bassett,et al.  Efficacy of Balloon Overtube‐Assisted Colonoscopy in Patients With Incomplete or Previous Difficult Colonoscopies: A Meta‐analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  K. Strasser-Weippl,et al.  Improving access to high‐cost cancer drugs in Latin America: Much to be done , 2017, Cancer.

[15]  D. Buist,et al.  Latina and Black/African American Women’s Perspectives on Cancer Screening and Cancer Screening Reminders , 2017, Journal of Racial and Ethnic Health Disparities.

[16]  J. A. Escamilla-Cejudo,et al.  Hispanic health in the USA: a scoping review of the literature , 2016, Public Health Reviews.

[17]  K. Lucas,et al.  Access to the Brazilian City—From the perspectives of low-income residents in Recife , 2016 .

[18]  K. Søreide,et al.  Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. , 2016, Cancer epidemiology.

[19]  J. Swann,et al.  The effect of geographic access on severe health outcomes for pediatric asthma. , 2015, The Journal of allergy and clinical immunology.

[20]  D. Morgan,et al.  The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison with United States Hispanic Populations , 2015, Journal of Gastrointestinal Cancer.

[21]  C. Antonescu,et al.  Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Talamantes,et al.  What Evidence is Available on End-of-life (EOL) Care and Latino Elders? A Literature Review , 2014, The American journal of hospice & palliative care.

[23]  Richard Sullivan,et al.  Planning cancer control in Latin America and the Caribbean. , 2013, The Lancet. Oncology.

[24]  R. Rodriguez,et al.  Fear of discovery among Latino immigrants presenting to the emergency department. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[25]  D. Morgan,et al.  Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America , 2012, Cancer Causes and Control.

[26]  B. Eisenberg,et al.  Gastrointestinal stromal tumor--background, pathology, treatment. , 2012, Hematology/oncology clinics of North America.

[27]  S. Diederich,et al.  Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group , 2012, Cancer imaging : the official publication of the International Cancer Imaging Society.

[28]  S. Fischer,et al.  Advance directive discussions: lost in translation or lost opportunities? , 2012, Journal of palliative medicine.

[29]  H. El‐Serag,et al.  The Epidemiology of Malignant Gastrointestinal Stromal Tumors: An Analysis of 1,458 Cases from 1992 to 2000 , 2005, The American Journal of Gastroenterology.

[30]  R. Laheij,et al.  Meta‐analysis: the diagnostic value of alarm symptoms for upper gastrointestinal malignancy , 2004, Alimentary pharmacology & therapeutics.

[31]  Myfanwy Morgan,et al.  What does 'access to health care' mean? , 2002, Journal of health services research & policy.

[32]  M. O'brien,et al.  Early gastric cancer. Clinicopathologic study. , 1985, The American journal of medicine.